NPI: 1679944003 · SUMMERVILLE, SC 29483 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 10/12/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 10/12/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,167 | $64K |
| 2019 | 5,955 | $34K |
| 2020 | 7,268 | $57K |
| 2021 | 3,338 | $48K |
| 2022 | 2,085 | $25K |
| 2023 | 421 | $113.09 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 10,675 | 1,208 | $176K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,746 | 689 | $33K |
| A4657 | Syringe, with or without needle, each | 877 | 699 | $11K |
| J1756 | Injection, iron sucrose, 1 mg | 1,002 | 398 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,901 | 556 | $1K |
| 83970 | 325 | 285 | $274.02 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 33 | 28 | $230.89 |
| 83540 | 240 | 193 | $111.14 | |
| 83550 | 240 | 193 | $95.91 | |
| 82728 | 236 | 194 | $88.31 | |
| 85048 | 462 | 432 | $61.34 | |
| 85041 | 462 | 432 | $58.33 | |
| 82108 | 35 | 32 | $17.05 |